The ??2-Agonist Controversy
- 1 October 1994
- journal article
- Published by Springer Nature in Drug Safety
- Vol. 11 (4) , 259-283
- https://doi.org/10.2165/00002018-199411040-00005
Abstract
No abstract availableThis publication has 96 references indexed in Scilit:
- Long term treatment of severe asthma with subcutaneous terbutalinePublished by Elsevier ,2004
- Risks Versus Benefits of Inhaled ??2-Agonists in the Management of AsthmaDrug Safety, 1992
- Chirality in antirheumatic drugsThe Lancet, 1991
- Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study.BMJ, 1991
- Increased bronchial hyperresponsiveness after inhaling salbutamol during 1 year is not caused by subsensitization to salbutamol1Journal of Allergy and Clinical Immunology, 1990
- Salbutamol in the 1980sDrugs, 1989
- Changes in Bronchial Reactivity in Asthmatic Children After Treatment with Beclomethasone Alone or in Association with SalbutamolJournal of Asthma, 1989
- Asthma drug therapy trends in the United States, 1972 to 1985Journal of Allergy and Clinical Immunology, 1987
- Decreased Beta-Adrenergic Receptors on Polymorphonuclear Leukocytes after Adrenergic TherapyNew England Journal of Medicine, 1978
- Use of exercise challenge to investigate possible tolerance to beta-adrenoceptor stimulation in asthmaRespiratory Medicine, 1978